4//SEC Filing
Levitz Michael L 4
Accession 0001171843-24-001461
CIK 0000898437other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 5:23 PM ET
Size
8.1 KB
Accession
0001171843-24-001461
Insider Transaction Report
Form 4
Levitz Michael L
EVP, CFO, Treasurer
Transactions
- Award
Restricted Stock Unit
2024-03-15+21,329→ 21,329 totalExercise: $0.00→ Common Stock (21,329 underlying) - Award
Stock Option (Right to Buy)
2024-03-15+51,682→ 51,682 totalExercise: $27.98Exp: 2034-03-11→ Common Stock (51,682 underlying)
Footnotes (3)
- [F1]Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025.
- [F2]Represents a 10% premium above the closing price of Anika's common stock on the date of grant.
- [F3]The premium priced stock options vest in three equal annual installments beginning on March 15, 2025.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001468019
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 5:23 PM ET
- Size
- 8.1 KB